Demographics and outcomes of meningioma patients treated at a tertiary care center in the Middle East.


Journal

Clinical neurology and neurosurgery
ISSN: 1872-6968
Titre abrégé: Clin Neurol Neurosurg
Pays: Netherlands
ID NLM: 7502039

Informations de publication

Date de publication:
08 2020
Historique:
received: 21 01 2020
revised: 05 03 2020
accepted: 09 04 2020
pubmed: 26 4 2020
medline: 16 6 2021
entrez: 26 4 2020
Statut: ppublish

Résumé

Meningioma is the most common intracranial primary brain tumor. Risk factors such as age and exposure to radiation as well as prognostic factors such as grade, location, and extent of surgical resection have been reported in the literature worldwide; however, to our knowledge, data from the Middle East is still warranted. In this study, we aim to identify the characteristics, risk factors and outcomes of meningioma patients treated at a multidisciplinary regional referral center in the Middle East. This is a retrospective chart review with a prospective follow up of outcomes. It included patients diagnosed with meningioma between January 2005 and December 2015 at the American University of Beirut Medical Center. Patient's demographics, risk factors and outcomes were first retrospectively collected. Then, we conducted phone calls to all included alive patients to update their disease status and outcomes. One-hundred and ninety-five patients were included. 69 % had grade I tumors and around 31 % with grades II and III meningiomas. The means of the overall survival and progression free survival (PFS) were 198 and 126 months, respectively. The residence area (city vs. countryside), occupation, alcohol use, oral contraceptive use, family history of meningioma, previous head trauma, radiation exposure for head/brain imaging, cell phone use, and finally, the tumor Ki-67 protein level did not correlate with the survival outcomes. The meningioma grade and extent of resection were significant predictors of the PFS on the univariate analysis, whereas, in the multivariate analysis only previous radiotherapy was significant in prolonging PFS. In our study cohort, that included around 30 % grades II and III tumors, previous radiotherapy use was the only significant prognostic factor for longer PFS in patients diagnosed with meningioma. Future prospective studies should be conducted to evaluate genetic and molecular factors that could possibly be linked to meningioma grade and prognosis in our population of Middle Eastern patients.

Identifiants

pubmed: 32334046
pii: S0303-8467(20)30189-X
doi: 10.1016/j.clineuro.2020.105846
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105846

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Hazem I Assi (HI)

Department of Internal Medicine, American University of Beirut Medical Center, Lebanon. Electronic address: ha157@aub.edu.lb.

Lara Hilal (L)

Department of Radiation Oncology, American University of Beirut Medical Center, Lebanon.

Ibrahim Abu-Gheida (I)

Department of Surgery, American University of Beirut Medical Center, Lebanon.

Juliett Berro (J)

Department of Internal Medicine, American University of Beirut Medical Center, Lebanon.

Fares Sukhon (F)

Department of Internal Medicine, American University of Beirut Medical Center, Lebanon.

Ghassan Skaf (G)

Department of Surgery, American University of Beirut Medical Center, Lebanon.

Fady Geara (F)

Department of Radiation Oncology, American University of Beirut Medical Center, Lebanon.

Fouad Boulos (F)

Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Lebanon.

Maya Charafeddine (M)

Department of Internal Medicine, American University of Beirut Medical Center, Lebanon.

Abeer Tabbarah (A)

Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Lebanon.

Jessica Khoury (J)

Department of Internal Medicine, American University of Beirut Medical Center, Lebanon.

Marwan Najjar (M)

Department of Surgery, American University of Beirut Medical Center, Lebanon. Electronic address: Mn12@aub.edu.lb.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH